Antipodes Partners
ALKS icon

Antipodes Partners’s Alkermes ALKS Stock Holding History

Antipodes Partners’s Portfolio ALKS Stock Details ALKS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$36.1K Buy
+890
New +$43.3K ﹤0.01% 126

Other funds holding ALKS

State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Renaissance Technologies
Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $161B AUM 86.05% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 38.25% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $77.1B AUM 11.99% 1-Year Est. Return

Antipodes Partners's ALKS Position: Q3 2026 in Review

Antipodes Partners opened a new position in Alkermes (ALKS) in Q3 2026: 890 shares worth $36.1K. The stake represents ﹤0.01% of the portfolio and ranks #126 among its holdings.

292 funds tracked by Wall St. Rank hold ALKS as of Q3 2026.

  • Antipodes Partners held 890 shares of Alkermes worth $36.1K as of Q3 2026.
  • Alkermes was a new Antipodes Partners position in Q3 2026.
  • Alkermes made up ﹤0.01% of Antipodes Partners's portfolio in Q3 2026, its #126 holding.
  • 292 funds tracked by Wall St. Rank held Alkermes as of Q3 2026.

Based on Antipodes Partners's 13F filing for Q3 2026, filed 5 Nov 2026.